The core components of CRISPR-based genome-editing therapies are bacterial proteins called nucleases that can stimulate ...

Genetic changes are a significant cause of infertility, impacting over 15% of the global population. TLE6, a major protein ...

Researchers have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal neurodegenerative condition. The treatment, which uses ...

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock. This data can help you ...

Infertility is a major global challenge associated with physiological and psychological impact. Genetic mutations that affect early embryonic ...

They used an engineered Cas9 protein having resemblance to Cas9 orthologs isolated from Francisella novicida (en31-FnCas9) but with altered PAM binding affinity. In their paper published in the ...

Bank of America Securities analyst Alec Stranahan maintained a Sell rating on Editas Medicine (EDIT – Research Report) yesterday and set a ...

the resulting protein could still have enough function to perform its critical roles." SPLICER builds upon the popular CRISPR-Cas9 gene editing platform -- with key changes. CRISPR-Cas9 systems ...

Gene editing involves precise changes in DNA sequences using enzymes, revolutionizing medical, agricultural, and research ...

Researchers have identified a molecular mechanism driving the structural abnormalities leading to lissencephaly that have ...

Editas Medicine (EDIT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Yanan Zhu ...

the resulting protein could still have enough function to perform its critical roles.” SPLICER builds upon the popular CRISPR-Cas9 gene editing platform — with key changes. CRISPR-Cas9 systems ...